These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27653222)

  • 21. Bone morphogenetic protein 7 sensitizes O6-methylguanine methyltransferase expressing-glioblastoma stem cells to clinically relevant dose of temozolomide.
    Tso JL; Yang S; Menjivar JC; Yamada K; Zhang Y; Hong I; Bui Y; Stream A; McBride WH; Liau LM; Nelson SF; Cloughesy TF; Yong WH; Lai A; Tso CL
    Mol Cancer; 2015 Nov; 14():189. PubMed ID: 26546412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dexamethasone decreases hepatocellular carcinoma cell sensitivity to cisplatin-induced apoptosis.
    Yang N; Zhang H; Si-Ma H; Fu Y; Zhao W; Li D; Yang G
    Hepatogastroenterology; 2011; 58(110-111):1730-5. PubMed ID: 21940343
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
    Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
    Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of D609 on the expression of GADD45β protein: Potential inhibitory role in the growth of glioblastoma cancer stem like cells.
    Kalluri HSG; Kuo JS; Dempsey RJ
    Eur J Pharmacol; 2016 Nov; 791():510-517. PubMed ID: 27658347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression pattern of protein markers for predicting chemosensitivity of dexamethasone-based chemotherapy of B cell acute lymphoblastic leukemia.
    Dehghan-Nayeri N; Eshghi P; Pour KG; Rezaei-Tavirani M; Omrani MD; Gharehbaghian A
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):177-185. PubMed ID: 28585036
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis.
    Adem J; Ropponen A; Eeva J; Eray M; Nuutinen U; Pelkonen J
    J Immunother; 2016 Jan; 39(1):8-14. PubMed ID: 26641257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
    Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
    Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
    Rath BH; Wahba A; Camphausen K; Tofilon PJ
    Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells.
    Sur P; Sribnick EA; Patel SJ; Ray SK; Banik NL
    Glia; 2005 Apr; 50(2):160-7. PubMed ID: 15685605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.
    Riva G; Butta V; Cilibrasi C; Baronchelli S; Redaelli S; Dalprà L; Lavitrano M; Bentivegna A
    Oncol Rep; 2016 May; 35(5):2811-24. PubMed ID: 26986767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anoxia induces macrophage inhibitory cytokine-1 (MIC-1) in glioblastoma cells independently of p53 and HIF-1.
    Albertoni M; Shaw PH; Nozaki M; Godard S; Tenan M; Hamou MF; Fairlie DW; Breit SN; Paralkar VM; de Tribolet N; Van Meir EG; Hegi ME
    Oncogene; 2002 Jun; 21(27):4212-9. PubMed ID: 12082608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest.
    Long PM; Tighe SW; Driscoll HE; Fortner KA; Viapiano MS; Jaworski DM
    J Cell Physiol; 2015 Aug; 230(8):1929-43. PubMed ID: 25573156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG.
    Shang C; Guo Y; Hong Y; Liu YH; Xue YX
    Mol Biol Rep; 2015 Mar; 42(3):721-7. PubMed ID: 25394756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic implications of interferon regulatory factor (IRF)-1 and IRF-2 in diffusely infiltrating astrocytomas (DIA): response to interferon (IFN)-beta in glioblastoma cells and prognostic value for DIA.
    Yoshino A; Katayama Y; Yokoyama T; Watanabe T; Ogino A; Ota T; Komine C; Fukushima T; Kusama K
    J Neurooncol; 2005 Sep; 74(3):249-60. PubMed ID: 16187022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteoprotegerin production by breast cancer cells is suppressed by dexamethasone and confers resistance against TRAIL-induced apoptosis.
    Rachner TD; Benad P; Rauner M; Goettsch C; Singh SK; Schoppet M; Hofbauer LC
    J Cell Biochem; 2009 Sep; 108(1):106-16. PubMed ID: 19544400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
    Aghi M; Rabkin S; Martuza RL
    J Natl Cancer Inst; 2006 Jan; 98(1):38-50. PubMed ID: 16391370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-135b suppresses tumorigenesis in glioblastoma stem-like cells impairing proliferation, migration and self-renewal.
    Lulli V; Buccarelli M; Martini M; Signore M; Biffoni M; Giannetti S; Morgante L; Marziali G; Ilari R; Pagliuca A; Larocca LM; De Maria R; Pallini R; Ricci-Vitiani L
    Oncotarget; 2015 Nov; 6(35):37241-56. PubMed ID: 26437223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.